After adding a black box label in 2020 to montelukast to indicate the ... In 2023, Reuters reported that Merck (MRK) is facing lawsuits alleging that the company knew from its early research ...

Merck, as a leading science and technology company, operates across healthcare, life sciences and performance materials. From advancing gene editing technologies and discovering unique ways to ...

ADCs have emerged as one key part of Merck's drive to diversify its cancer pipeline, for example with a $1 billion investment in Seagen in 2020 that gave it rights to the biotech's LIV-1-targeting ...

A career highlight has been seeing my graduate students grow as first year students into independent and creative scientists. Professor Vy Dong Although not observable by the naked eye, molecules are ...

according to data that will be presented at the virtual ASCO 2020 congress that starts later this month. The study showed that Merck’s drug was effective in previously-untreated TNBC patients ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

RAHWAY, N.J., January 08, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the National Medical Products Administration (NMPA ...